Capecitabine plus oxaliplatin in the treatment of metastatic colorectal cancer at Tygerberg Hospital: a retrospective study

INTRODUCTION: a capecitabine and oxaliplatin drug combination regimen has shown a survival benefit in patients with advanced colorectal cancer, yet its administration represents an attractive option for low resource settings. This study aimed to describe the therapeutic utility, efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Kibudde, Solomon, Begg, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463746/
https://www.ncbi.nlm.nih.gov/pubmed/36160274
http://dx.doi.org/10.11604/pamj.2022.42.141.31234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463746/
https://www.ncbi.nlm.nih.gov/pubmed/36160274
http://dx.doi.org/10.11604/pamj.2022.42.141.31234

Ejemplares similares